|
|
||||||||
From the Departments of Neurology (N.P.Y., E.J.S., J.R.D.) and Neurosurgery (R.J.S.), Mayo Clinic, Rochester, MN.
Address correspondence and reprint requests to Dr. Nathan Young, Department of Neurology, Mayo Clinic, 200 1st St. SW, Rochester, MN 55905 young.nathan{at}mayo.edu
Objective: Intraneural ganglia (IG) are an underappreciated but treatable cause of common peroneal neuropathy (CPN). This study was designed to determine if there are clinical measures that distinguish CPN caused by IG from CPN without a clear proximate cause.
Methods: Clinical and electrodiagnostic features of 22 cases of IG were compared in a case-control study to 11 cases of CPN with imaging negative for IG.
Results: The IG group had a greater body mass index (30 vs 24; p < 0.005), more pain at the knee (52% of 22 vs 0% of 11; p < 0.005) or in the peroneal distribution (76% of 21 vs 27% of 1; p < 0.02), more frequent fluctuating weakness (48% of 21 vs 4% of 29; p < 0.01) with weight bearing (38%, p < 0.05), or a palpable mass (47% of 20, p < 0.01) at the fibular head. The IG group was less likely to present with a history of weight loss (0% vs 36%; p < 0.01), immobility (0% vs 21%; p < 0.03), or leg crossing (0% vs 80%; p < 0.05). There were no significant electrophysiologic differences.
Conclusions: Presenting clinical features increase the likelihood of intraneural ganglia and may assist selection of patients with common peroneal neuropathy for diagnostic peroneal nerve imaging.
Abbreviations: AFO = ankle-foot orthosis; BMI = body mass index; CMAP = compound muscle action potential; CPN = common peroneal neuropathy; EDB = extensor digitorum brevis; IG = intraneural ganglia; NCS = nerve conduction study; PL = peroneus longus; TA = tibialis anterior.
Disclosure: The authors report no disclosures.
Received August 18, 2008. Accepted in final form October 24, 2008.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |